Back
Innovative Designs 10K Form
Buy
54
IVDN
Innovative Designs
Last Price:
0.1000
Seasonality Move:
4.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-09-21 | 10Q | IVDN/Innovative Designs Quarterly |
2020-08-10 | 10Q | IVDN/Innovative Designs Quarterly |
2020-04-30 | 10Q | IVDN/Innovative Designs Quarterly |
2020-03-25 | 10K | IVDN/Innovative Designs Annual |
2019-10-31 | 10Q | IVDN/Innovative Designs Quarterly |
2019-08-15 | 10K | IVDN/Innovative Designs Annual |
Receive IVDN News And Ratings
See the #1 stock for the next 7 days that we like better than IVDN
IVDN Financial Statistics
Sales & Book Value
Annual Sales: | $347.76K |
---|---|
Cash Flow: | $-122.9K |
Price / Cash Flow: | 0 |
Annual Sales: | $0.03 |
Price / Book: | 2.98 |
Profitability
EPS (TTM): | -0.01000 |
---|---|
Net Income (TTM): | $-305.7K |
Gross Margin: | $179.98K |
Return on Equity: | -28.1% |
Return on Assets: | -20.68% |
Innovative Designs Earnings Forecast
Key Innovative Designs Financial Ratios
- The Gross Profit Margin over the past 21 years for IVDN is 51.75%.
- The Selling, General & Administrative Expenses for IVDN have been equal to 133.45% of Gross Profit Margin.
- The Interest Expense is -8.23% of Operating Income.
- The Net Earning history of IVDN is -86.66% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 7 years.
Innovative Designs Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | OTCM |
---|---|
Industry: | Leisure Products |
Sector: | Consumer Discretionary |
Current Symbol: | IVDN |
Website: | idigear.com |
Debt
Debt-to-Equity Ratio: | 0.09 |
---|---|
Current Ratio: | 4.08 |
Quick Ratio: | 1.08 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
IVDN Technical Analysis vs Fundamental Analysis
Buy
54
Innovative Designs (IVDN)
is a Buy
Is Innovative Designs a Buy or a Sell?
-
Innovative Designs stock is rated a Buy
The current Innovative Designs [IVDN] share price is $0.1000. The Score for IVDN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.